Skip to main content
Advertisement
Table of Contents

July 2024

Cover

Nonspecific abdominal symptoms, such as pain or bloating, are frequently observed in primary care settings, usually with benign causes, but may be indicative of undiagnosed cancer. Patients with these symptoms often undergo routine blood tests that could help identify those at higher risk for cancer, thereby helping to prioritize referrals and determine who can be safely monitored in the primary care setting. Currently, there is little evidence to support the value of abnormal blood tests for cancer risk assessment in patients with these symptoms. In this issue, Meena Rafiq and team evaluate the predictive value of 19 abnormal blood test results for cancer detection in patients presenting with new abdominal pain or bloating.

Image Credit: Karolina Kaboompics on Pexels

Perspective

Research on the treatment of rifampin-susceptible tuberculosis—Time for a new approach

William Burman, Oxana Rucsineanu, C. Robert Horsburgh, James Johnston, Susan E. Dorman, Dick Menzies

Research Articles

Direct factor Xa inhibitors and the risk of cancer and cancer mortality: A Danish population-based cohort study

Floris Bosch, Erzsébet Horváth-Puhó, Suzanne C. Cannegieter, Nick van Es, Henrik T. Sørensen

Association between achieving adequate antenatal care and health-seeking behaviors: A study of Demographic and Health Surveys in 47 low- and middle-income countries

Boshen Jiao, Isabelle Iversen, Ryoko Sato, Clint Pecenka, Sadaf Khan, Ranju Baral, Margaret E. Kruk, Catherine Arsenault, Stéphane Verguet

Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: A stepped wedge cluster randomised trial

Maryam de Brun, Anders Magnuson, Scott Montgomery, Snehal Patil, David Simmons, Kerstin Berntorp, Stefan Jansson, Ulla-Britt Wennerholm, Anna-Karin Wikström, Helen Strevens, Fredrik Ahlsson, Verena Sengpiel, Erik Schwarcz, Elisabeth Storck-Lindholm, Martina Persson, Kerstin Petersson, Linda Ryen, Carina Ursing, Karin Hildén, Helena Backman

Assessing thresholds of resistance prevalence at which empiric treatment of gonorrhea should change among men who have sex with men in the US: A cost-effectiveness analysis

Xuecheng Yin, Yunfei Li, Minttu M. Rönn, Song Li, Yue Yuan, Thomas L. Gift, Katherine Hsu, Joshua A. Salomon, Yonatan H. Grad, Reza Yaesoubi

Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study

Xin Qian, Jinping Wang, Qiuhong Gong, Yali An, Xinxing Feng, Siyao He, Xiaoping Chen, Wenjuan Wang, Lihong Zhang, Yuanchi Hui, Xiuwei Zhai, Bo Zhang, Yanyan Chen, Guangwei Li

The impact of primary health care on AIDS incidence and mortality: A cohort study of 3.4 million Brazilians

Priscila F. P. S. Pinto, James Macinko, Andréa F. Silva, Iracema Lua, Gabriela Jesus, Laio Magno, Carlos A. S. Teles Santos, Maria Yury Ichihara, Mauricio L. Barreto, Corrina Moucheraud, Luis E. Souza, Inês Dourado, Davide Rasella

Related Articles

Deaths with COVID-19 and from all-causes following first-ever SARS-CoV-2 infection in individuals with preexisting mental disorders: A national cohort study from Czechia

Tomáš Formánek, Libor Potočár, Katrin Wolfova, Hana Melicharová, Karolína Mladá, Anna Wiedemann, Danni Chen, Pavel Mohr, Petr Winkler, Peter B. Jones, Jiří Jarkovský

Comparing cervical cerclage, pessary and vaginal progesterone for prevention of preterm birth in women with a short cervix (SuPPoRT): A multicentre randomised controlled trial

Natasha L. Hezelgrave, Natalie Suff, Paul Seed, Vicky Robinson, Jenny Carter, Helena Watson, Alexandra Ridout, Anna L. David, Susana Pereira, Fatemeh Hoveyda, Joanna Girling, Latha Vinayakarao, Rachel M. Tribe, Andrew H. Shennan, the SuPPoRT Collaborating Team

Related Articles

Estimated reduction in obesity prevalence and costs of a 20% and 30% ad valorem excise tax to sugar-sweetened beverages in Brazil: A modeling study

Ana Basto-Abreu, Rossana Torres-Alvarez, Tonatiuh Barrientos-Gutierrez, Paula Pereda, Ana Clara Duran

Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study

Gabrielle Bonnet, John Bimba, Chancy Chavula, Harunavamwe N. Chifamba, Titus H. Divala, Andres G. Lescano, Mohammed Majam, Danjuma Mbo, Auliya A. Suwantika, Marco A. Tovar, Pragya Yadav, Obinna Ekwunife, Collin Mangenah, Lucky G. Ngwira, Elizabeth L. Corbett, Mark Jit, Anna Vassall

New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling

Sarah Cadot, Chloe Audebert, Charlotte Dion, Soleakhena Ken, Loic Dupré, Laetitia Largeaud, Camille Laurent, Loic Ysebaert, Fabien Crauste, Anne Quillet-Mary

Predictive value of abnormal blood tests for detecting cancer in primary care patients with nonspecific abdominal symptoms: A population-based cohort study of 477,870 patients in England

Meena Rafiq, Cristina Renzi, Becky White, Nadine Zakkak, Brian Nicholson, Georgios Lyratzopoulos, Matthew Barclay

Using contact network dynamics to implement efficient interventions against pathogen spread in hospital settings: A modelling study

Quentin J. Leclerc, Audrey Duval, Didier Guillemot, Lulla Opatowski, Laura Temime